https://orcid.org/0000-0002-3646-657X
References
- ClemensR , SängerR , KruppenbacherJet al.Booster immunization of low-and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance. Vaccine15(4), 349–352 (1997).
- HeQ , MaoQ , AnCet al.Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerg. Microbes Infect.10(1), 629–637 (2021).
- AtanackovicD , AltorkiNK , CaoYet al.Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proc. Natl Acad. Sci. USA105(5), 1650–1655 (2008).
- YiY , YuM , LiW , ZhuD , MeiL , OuM. Vaccine-like nanomedicine for cancer immunotherapy. J. Controlled Release355, 760–778 (2023).
- CollinsDR , GaihaGD , WalkerBD. CD8+ T cells in HIV control, cure and prevention. Nat. Rev. Immunol.20(8), 471–482 (2020).
- ZhuangC , LiuX , ChenQet al.Protection duration of COVID-19 vaccines: waning effectiveness and future perspective. Front. Microbiol.13, 828806 (2022).
- LoCY , MisplonJA , LiX , PriceGE , YeZ , EpsteinSL. Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice. Vaccine39(33), 4628–4640 (2021).
- DuijzerLE , Van JaarsveldW , DekkerR. Literature review: the vaccine supply chain. Eur. J. Oper. Res.268(1), 174–192 (2018).
- EminiEA , JamesonBA , WimmerE. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature304(5928), 699–703 (1983).
- HuSL , KlanieckiJ , DykersT , SridharP , TravisBM. Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Res.7(7), 615–620 (1991).
- HuSL , AbramsK , BarberGNet al.Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science255(5043), 456–459 (1992).
- GirardM , KienyMP , PinterAet al.Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl Acad. Sci. USA88(2), 542–546 (1991).
- ZaguryD , BernardJ , CheynierRet al.A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature332, 728–731 (1988).
- BandellAR , SimõesE. Live attenuated influenza vaccine tetravalent: a clinical review. Expert Rev. Vaccines14(7), 963–973 (2015).
- FuJYL , PukhariMH , BadorMK , SamIC , ChanYF. Humoral and T cell immune responses against SARS-CoV-2 after primary and homologous or heterologous booster vaccinations and breakthrough infection: a Longitudinal Cohort Study in Malaysia. Viruses15(4), 844 (2023).
- VaineM. Antibody responses elicited by DNA prime-protein boost HIV vaccines: a dissertation (2010). https://doi.org/10.13028/ypgp-5r25
- SchmidtT , KlemisV , SchubDet al.Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients. Am. J. Transplant.21, 3990–4002 (2021).
- ShengWH , HsiehSM , ChangSC. Achievements of COVID-19 vaccination programs: taiwanese perspective. J. Formos. Med. Assoc. (2023). https://doi.org/10.1016/j.jfma.2023.04.017
- NguyenTT , QuachTHT , TranTMet al.Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine. Biomed. Pharmacother.147, 112650 (2022).
- GargI , SheikhAB , PalS , ShekharR. Mix-and-match COVID-19 vaccinations (heterologous boost): a review. Infect. Dis. Rep.14(4), 537–546 (2022).